Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 517.00 M

Quest Diagnostics Incorporated Depreciation And Amortization is USD 517.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 15.40% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 448.00 M, a 2.28% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 438.00 M, a 6.05% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 413.00 M, a 9.55% change year over year.
  • Quest Diagnostics Incorporated Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 377.00 M, a 14.24% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased